SynthesisNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2025

Effect of Tirzepatide on arrhythmic, major cardiovascular, and neurological outcomes in patients with type 2 diabetes: A systematic review and meta-analysis.

What moved togetherboth groups pooled, not the treatment’s effect

Correlation · may be no link

1.4×0.5× to 3.7×

Bigger than 7 in 10 for cardiovascular events

As reported

RR 1.39, 95% CI 0.53–3.67

Correlation · may be no link

1.1×0.2× to 6.5×

Bigger than 2 in 10 for cardiovascular events

As reported

RR 1.14, 95% CI 0.20–6.55

the abstract, start to end

… including atrial fibrillation (AF) (RR 1.39, 95% CI 0.53 to 3.67) and atrial flutter (AFL) (RR 1.14, 95% CI 0.20 to 6.55).

← favours treatmentfavours comparator →

could be chance

Cardiovascular events

RR 1.390.53–3.67

Cardiovascular events

RR 1.140.20–6.55

GIP/GLP-1 & amylin agonistsCardiovascular events

1 / 3